This page shows the latest IWS news and features for those working in and with pharma, biotech and healthcare.
Another contender is Cyclerion Therapeutics's praliciguat (IW-1973), an oral soluble guanylate cyclase (sGC) stimulator currently in phase 2 trials.
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...